Ireland CDMO Directory · Dundalk, Co. Louth
WuXi Biologics Dundalk
Biologics Drug Substance & Drug Product
600+ (2024 campus figure)
Employees
48,000L Bioreactor Capacity
Facility
Louth
County
2
Certifications
Facility Overview
Ireland's first WuXi Biologics manufacturing site (announced 2018, €325M initial investment), featuring 48,000L fed-batch bioreactor capacity using single-use and continuous bioprocessing technology. Distinct from the adjacent WuXi Vaccines facility on the same campus, which was sold to Merck/MSD in 2025 — this biologics drug substance/drug product plant remains WuXi-operated and gained EMA commercial manufacturing approval in August 2025.
ISPE Facility of the Year 2023 — 48,000L single-use biomanufacturing plant
Capabilities
Biologics Manufacturing
Single-Use Bioreactors
Monoclonal Antibodies
Recombinant Proteins
Continuous Bioprocessing
Certifications & Regulatory Licenses
HPRA Licensed
EMA (EU GMP) — commercial approval Aug 2025